DailyDoctor Archive Specialties Get app
Back to the 9 September 2026 edition

Clinical update · 02 of 06

Do not shrink the operation because the tumour shrank

A good radiological response to neoadjuvant immunotherapy is not yet a reason to reduce the resection - regression is heterogeneous and response assessment unreliable, so plan margins to the pre-treatment extent.

Neoadjuvant immunotherapy is moving into the management of resectable locally advanced mucosal head and neck squamous cell carcinoma, and with it comes the tempting proposition that a good response should permit a smaller resection. This commentary sets out why that inference is not yet safe.

Two problems are named. Response assessment in this setting is unreliable - imaging and clinical examination after immunotherapy do not map cleanly onto residual viable tumour. And regression is heterogeneous: tumours do not shrink concentrically towards a centre, so a radiologically smaller mass may still contain viable disease scattered through the original footprint. A resection planned to the post-treatment volume can therefore leave tumour behind in tissue that looked clear.

This is a commentary rather than a study, so it produces no numbers to weigh, and it does not argue against neoadjuvant immunotherapy. It argues against response-adapted surgical de-escalation until prospective trials have shown where the margins should sit. Until then, plan the resection to the pre-treatment extent, discuss the distinction explicitly in the multidisciplinary meeting so that the radiological response is not silently read as a change to the surgical plan, and consent the patient on that basis.

  • Plan resection margins to the pre-treatment tumour extent, not the post-treatment imaging.
  • Record the pre-treatment mapping formally before immunotherapy starts, so it is available at operation.
  • Say explicitly in the multidisciplinary meeting whether a good response is changing the surgical plan - and by default it should not.
  • Treat pathological response assessment as research data at present, not as a surgical decision tool.
  • Consent the patient for the operation the pre-treatment disease required.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

rhinologyheadneckoncotologypaedent

Tomorrow morning, before your first patient

One edition a day for ent & head and neck surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app